The CLL2-BAAG trial provides further evidence supporting a minimal residual disease driven approach and triple therapy in relapsed chronic lymphocytic leukaemia
@article{ACTR10820, author = {Abraham Mullasseril Varghese and Talha Munir}, title = {The CLL2-BAAG trial provides further evidence supporting a minimal residual disease driven approach and triple therapy in relapsed chronic lymphocytic leukaemia}, journal = {AME Clinical Trials Review}, volume = {0}, number = {0}, year = {2025}, keywords = {}, abstract = {}, issn = {3005-6152}, url = {https://actr.amegroups.org/article/view/10820} }